Highlights
TSXV: RVV       Revive Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
0.18   +0.01 (5.88%)  0.165 - 0.18  112,450

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:0.09 - 0.44
52 Weeks Price Volatility (%):
25.71%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Revive Therapeutics Ltd (Revive) is engaged in commercializing treatments for rare diseases, such as Cystinuria, Wilson's disease and Rett syndrome. The Company has completed a Phase II-A study for acute gout flares in the United States. The Company's business model focuses on finding new uses of old drugs with the objective of finding a partner or partners to bring the new use drug to the marketplace. The Company is focused on the development of Bucillamine for the treatment of cystinuria (REV-004). The Company's product pipeline includes Bucillamine for the treatment of acute gout flares (REV-002), Tianeptine for treatment of Rett Syndrome (REV-003), and Bucillamine for treatment of Wilson's disease (REV-005). The Company is focused on the development and commercialization of drugs for underserved medical needs. The Company is also evaluating additional drug repurposing candidates and formulations.

  Be the first to like this.
 


 

832  744  746  2030 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BBD.B 2.14-0.09 
 EVC 0.135+0.005 
 PGF 1.49+0.33 
 BTO 3.56+0.29 
 XOP 0.03+0.01 
 ECA 14.13+0.24 
 CAF 0.065+0.005 
 CVE 12.79+0.10 
 MXL 0.18+0.01 
 HOU 6.585+0.375 
Partners & Brokers